
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Clearside Biomedical
Clearside Biomedical, Inc. operates as a biopharmaceutical company. The Company focuses on developing drug therapies to treat blinding diseases of the eye affecting the retina and choroid. Clearside Biomedical serves patients worldwide.
Stock Analysis

last close
$1.61
1-mo return
-6.9%
3-mo return
10.3%
avg daily vol.
120.03T
52-week high
7.73
52-week low
1.26
market cap.
$100M
forward pe
-
annual div.
-
roe
0.34%
ltg forecast
-
dividend yield
-
annual rev.
$30M
inst own.
35.4%